Status:
COMPLETED
Evaluation of Antibody Tests for COVID-19
Lead Sponsor:
Washington University School of Medicine
Conditions:
COVID
Coronavirus
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to evaluate the sensitivity and specificity of several marketed commercial or prototype test kits for antibody to SARS-CoV-2. The focus will be on rapid-format, point-of-c...
Detailed Description
Background Molecular (RT-PCR) tests are currently the gold standard for diagnosis of COVID-19. They detect viral RNA and are a good marker for current infection and infectivity. However, these tests ...
Eligibility Criteria
Inclusion
- Sera/plasma from patients who have been hospitalized and tested positive for SARS-CoV-2
- Sera/plasma from people who have recovered from COVID-19
- Sera/plasma from from healthy humans and persons with parasitic diseases
Exclusion
- Persons under the age of 18
Key Trial Info
Start Date :
April 23 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 8 2020
Estimated Enrollment :
461 Patients enrolled
Trial Details
Trial ID
NCT04360954
Start Date
April 23 2020
End Date
July 8 2020
Last Update
June 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110